Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited
- 1 October 1998
- journal article
- review article
- Published by Microbiology Society in Microbiology
- Vol. 144 (10) , 2673-2678
- https://doi.org/10.1099/00221287-144-10-2673
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- DNA Sequence Sampling of theStreptococcus pneumoniaeGenome to Identify Novel Targets for Antibiotic DevelopmentMicrobial Drug Resistance, 1998
- d-AMINO ACIDS IN ANIMAL PEPTIDESAnnual Review of Biochemistry, 1997
- Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancyThe Lancet, 1994
- Identification and sequence of a Na+‐linked gene from the marine bacterium Alteromonas haloplanktis which functionally complements the dagA gene of Escherichia coliMolecular Microbiology, 1992
- The murein hydrolases of Escherichia coli: properties, functions and impact on the course of infections in vivoJournal of General Microbiology, 1991
- Treatment of Chlamydia trachomatis Genital InfectionClinical Infectious Diseases, 1990
- Nucleotide sequence of the gene for the peptidoglycan‐associated lipoprotein of Escherichia coli K12European Journal of Biochemistry, 1987
- Molecular genetic evidence for early evolutionary origin of budding peptidoglycan-less eubacteriaNature, 1984
- A Search for the Bacterial Mucopeptide Component, Muramic Acid, in ChlamydiaJournal of General Microbiology, 1974
- Cell-wall Constituents of Rickettsiae and Psittacosis-Lymphogranuloma OrganismsJournal of General Microbiology, 1963